Merck & Co., Inc. Proceeds from Stock Issuance 2007-2026 | MRK
Beta
What is Merck & Co., Inc.'s current proceeds from stock issuance?
Merck & Co., Inc. (MRK) annual proceeds from stock issuance for 2025 was $92.0M, a 48.02% decline from 2024. Merck & Co., Inc. proceeds from stock issuance for the quarter ending March 31, 2026 was $157.0M.
What was Merck & Co., Inc.'s proceeds from stock issuance in 2024?
Merck & Co., Inc. annual proceeds from stock issuance for 2024 was $177.0M, a 41.60% increase from 2023.
What was Merck & Co., Inc.'s proceeds from stock issuance in 2023?
Merck & Co., Inc. annual proceeds from stock issuance for 2023 was $125.0M, a 67.45% decline from 2022.
What is Merck & Co., Inc.'s 5-year proceeds from stock issuance CAGR?
Merck & Co., Inc. proceeds from stock issuance grew at a compound annual growth rate (CAGR) of 0.67% from FY2020 to FY2025, going from $89.0M to $92.0M over 5 years.
Proceeds from Stock Issuance History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR+0.7%
FY2020
$89.0M
→
FY2025
$92.0M
07080910111213141516171819202122232425
5 years selected
Proceeds from Stock Issuance History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $92.0M | -48.0% | 10-K |
| FY2024 | $177.0M | +41.6% | 10-K |
| FY2023 | $125.0M | -67.4% | 10-K |
| FY2022 | $384.0M | +90.1% | 10-K |
| FY2021 | $202.0M | +127.0% | 10-K |
| FY2020 | $89.0M | -75.3% | 10-K |
| FY2019 | $361.0M | -38.9% | 10-K |
| FY2018 | $591.0M | +18.4% | 10-K |
| FY2017 | $499.0M | -46.9% | 10-K |
| FY2016 | $939.0M | +93.6% | 10-K |
| FY2015 | $485.0M | -68.9% | 10-K |
| FY2014 | $1.56B | +28.9% | 10-K |
| FY2013 | $1.21B | -7.6% | 10-K |
| FY2012 | $1.31B | +308.1% | 10-K |
| FY2011 | $321.0M | -11.6% | 10-K |
| FY2010 | $363.0M | +95.2% | 10-K |
| FY2009 | $186.0M | +82.4% | 10-K |
| FY2008 | $102.0M | -88.6% | 10-K |
| FY2007 | $898.6M | - | 10-K |
Company: Merck & Co., Inc.Ticker: MRKSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →